OPALEYE MANAGEMENT INC. 4D Molecular Therapeutics, Inc. Transaction History

OPALEYE MANAGEMENT INC. portfolio value:

$2.82M
portfolio value

OPALEYE MANAGEMENT INC. quarter portfolio value change:

+15.19%
quarter

4D Molecular Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +7.91% 25.7K shares 551K $8.04 350.7K
Q2 2022 share 0.00% 0 shares -2.64M $6.98 325K
Q1 2022 share Increase +41.92% 96K shares -110K $15.12 325K
Q4 2021 share Increase 0.00% 229K shares 5.02M $21.87 229K